Companies/4BASEBIO UK SOCIETAS
Follow
4BASEBIO UK SOCIETAS
London AIM (United Kingdom)
4basebio UK Societas is a specialist life sciences group focused on therapeutic DNA for gene therapies and DNA vaccines and providing solutions for effective and safe delivery of these DNA based products to patients. Its main country of operation is the UK. It is the intention of the Company to become a market leader in the manufacture and supply of high purity, synthetic DNA for research, therapeutic and pharmacological use. The principal objective of 4bb is to validate and scale its DNA synthesis process 4basebio UK Societas is a specialist life sciences group focused on therapeutic DNA for gene therapies and DNA vaccines and providing solutions for effective and safe delivery of these DNA based products to patients. Its main country of operation is the UK. It is the intention of the Company to become a market leader in the manufacture and supply of high purity, synthetic DNA for research, therapeutic and pharmacological use. The principal objective of 4bb is to validate and scale its DNA synthesis process with a view to manufacturing Good Manufacturing Practice ("GMP") grade DNA, suitable for use in gene therapies and DNA vaccines.

Read more

Sector:
HEALTH CARE
Media
www.4basebio.com
Current instruments
Type
Ticker
ISIN
SHARE
4BB ORD EUR1.00
GB00BLD8ZL39
London AIM United Kingdom (GB)
Top
News
Second Price Monitoring Extn
25 Feb 2021 - 09:05
Price Monitoring Extension
25 Feb 2021 - 09:00
TruePrime Technology
13 Feb 2021 - 18:13
Instruments & Events
The shares and options available for this company. Including past events like IPOs, direct listings and exercise periods.
Type
Ticker
ISIN
Market
SHARE
4BB ORD EUR1.00
GB00BLD8ZL39
London AIM
United Kingdom (GB)
Details of share in 4BASEBIO UK SOCIETAS with ticker 4BB ORD EUR1.00
Status
Active
SEDOL
BLD8ZL3
Amount of instruments
—
Par value
—
Currency
—
Segment
ASQ1
Type
Price
Pre-money valuation
Time
Files
Listing
118 pence
14.53M GBP
17 Feb 2021
Direct listing of 4BASEBIO UK SOCIETAS on London AIM
Please sign in to view full information or sign up for FREE.

What will You get:

An IPOhub original research paper about TOP10 Nordic IPOs in 2020

Whitepaper "TOP10 Nordic IPOs in 2020" by IPOhub

Fresh Data, updated daily:

  • Active and Upcoming Events - IPO’s , New Share Issues, Exercises, Market moves, Upcoming Listings,Acquisitions.
  • Live Press releases (news and media)
  • Updates on Your favorite prospects to Your email.

For investment decisions:

  • Info on 600+ IPOs, 1400+ listings and 5000+ share issue events.
  • Access to database with 3000+ growth companies.
  • Data which is collected and brought to You from 100+ sources.

Save time and make better investment decisions with IPOhub. Sign up now until it`s FREE!

Sign up for free
People
Heikki Lanckriet
CEO
Timothy Paul McCarthy
Chairman of the board
David John Roth
Board member
Hansjörg Plaggemars
Board member
Joseph Manuel Fernández
Board member
Maria del Pilar de la Huerta Martinez
Board member
Company Details
Sector
HEALTH CARE
Website
Address
25 Norman Way
Zip code
CB24 5QE
City/district
Cambridge
Country
United Kingdom (GB)
Phones
Email
info@4basebio.com
Registration number
SE000143
LEI code
2138005D5SAG8FIR6G91
First trade date
17 Feb 2021
Registration date
05 Nov 2019
Short name
4basebio

We use cookies to make your experience using IPOhub better. By using our site you agree to our use of cookies. Learn More